电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

JAM3 抗体 (FITC)

This anti-JAM3 antibody is a 大鼠 单克隆 antibody detecting JAM3 in FACS 和 IF. Suitable for 人 和 小鼠. This Primary Antibody has been cited in 3+ publications.
产品编号 ABIN2475174
发货至: 中国

Quick Overview for JAM3 抗体 (FITC) (ABIN2475174)

抗原

See all JAM3 抗体
JAM3 (Junctional Adhesion Molecule 3 (JAM3))

适用

  • 49
  • 40
  • 24
  • 5
  • 5
  • 4
  • 3
  • 2
  • 2
  • 1
人, 小鼠

宿主

  • 41
  • 10
  • 5
大鼠

克隆类型

  • 41
  • 15
单克隆

标记

  • 31
  • 4
  • 4
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This JAM3 antibody is conjugated to FITC

应用范围

  • 41
  • 15
  • 14
  • 14
  • 13
  • 13
  • 10
  • 10
  • 7
  • 6
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Flow Cytometry (FACS), Immunofluorescence (IF)

克隆位点

CRAM-18 F26
  • 交叉反应

    产品特性

    Purified IgG conjugated to Fluorescein Isothiocyanate Isomer 1 (FITC)

    免疫原

    Recombinant soluble JAM-C

    亚型

    IgG2a
  • 应用备注

    Optimal working dilution should be determined by the investigator.

    限制

    仅限研究用
  • 状态

    Liquid

    浓度

    0.1 mg/mL
  • Johnson-Léger, Aurrand-Lions, Beltraminelli, Fasel, Imhof: "Junctional adhesion molecule-2 (JAM-2) promotes lymphocyte transendothelial migration." in: Blood, Vol. 100, Issue 7, pp. 2479-86, (2002) (PubMed).

    Aurrand-Lions, Duncan, Ballestrem, Imhof: "JAM-2, a novel immunoglobulin superfamily molecule, expressed by endothelial and lymphatic cells." in: The Journal of biological chemistry, Vol. 276, Issue 4, pp. 2733-41, (2001) (PubMed).

    Aurrand-Lions, Johnson-Leger, Wong, Du Pasquier, Imhof: "Heterogeneity of endothelial junctions is reflected by differential expression and specific subcellular localization of the three JAM family members." in: Blood, Vol. 98, Issue 13, pp. 3699-707, (2001) (PubMed).

  • 抗原

    JAM3 (Junctional Adhesion Molecule 3 (JAM3))

    别名

    JAM-C

    背景

    Synonyms: JAM-3

    基因ID

    83700, 83964

    UniProt

    Q9BX67, Q9D8B7
You are here:
Chat with us!